triazavirin tzv riamilovir broadspectrum antivir drug develop russia joint effort ural feder univers russian academi scienc ural center biopharma technolog medsintez pharmaceut novel triazolotriazin core repres new structur class nonnucleosid antivir drug main principl action triazavirin inhibit synthesi viral ribonucl acid rna replic viral genom fragment synthet analogu basi purin nucleosid origin develop potenti treatment pandem influenza strain hn test focus antiinfluenza activ howev triazavirin also find antivir activ number virus includ tickborn enceph virus forestspr enceph virus also investig potenti applic lethal influenza infect secondari bacteri pneumonia follow influenza lassa fever ebola virus diseas triazavirin pass clinic trial show antivir activ arvi test triazavirin start sarscov russia china south africa triazavirin also find antivir activ sarscov august ministri health russia issu registr certif triazavirin activ substanc drug triazavirin new activ molecul dispens prescript product triazavirin carri modern pharmaceut enterpris llc plant medsintez registr procedur triazavirin begin republ south africa antiinfect drug articl stub help wikipedia expand